NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The Thanksgiving Day 2023 SNO Hit (lying) Piece, potentially initially submitted nearly a year ago, criticized research, (aside from their lying critiques), that did not include longitudinal analysis.

Longitudinal analysis is how the patient and/or immune system respond to immunotherapy over time.

The Thanksgiving day hit article came out less than one week after Dr. Bosch, Dr. Liau and Dr. Ashkan presented a seminal abstract, utilizing “-omics,” demonstrating:

Expansion of several hundred new T cell clones as well as more than 700 previously detected T cell clones was detected over time in both newly diagnosed and recurrent GBM patients who were treated with the pulsed DCs. Investigation of the dynamics of the response demonstrated that further expansion was triggered by ongoing immunizations. Correlations between T cell response data and clinical outcomes are ongoing.

Of course the abstract was a synthesis of Dr. Bosch’s ASCO presentation five months earlier.

Curiouser and curiouser. Look now at the final sentence in the abstract above. Here it is again:

Correlations between T cell response data and clinical outcomes are ongoing.

Remember, the SNO abstract deadline was due by June 9, 2023, just six days after Dr. Bosch presented at ASCO and more than five months before SNO.